Huntington National Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Sell
691,757
-17,586
-2% -$460K 0.08% 173
2026
Q1
$19.9M Buy
709,343
+194,367
+38% +$5.17M 0.11% 154
2025
Q4
$12.8M Sell
514,976
-22,317
-4% -$563K 0.08% 170
2025
Q3
$13.7M Sell
537,293
-32,116
-6% -$793K 0.08% 171
2025
Q2
$13.8M Sell
569,409
-34,271
-6% -$799K 0.09% 163
2025
Q1
$15.3M Sell
603,680
-64,980
-10% -$1.7M 0.11% 151
2024
Q4
$17.7M Sell
668,660
-71,695
-10% -$1.94M 0.13% 141
2024
Q3
$21.4M Sell
740,355
-22,520
-3% -$657K 0.16% 128
2024
Q2
$21.3M Sell
762,875
-31,669
-4% -$872K 0.17% 122
2024
Q1
$22M Sell
794,544
-121,009
-13% -$3.36M 0.18% 122
2023
Q4
$26.4M Sell
915,553
-84,658
-8% -$2.56M 0.24% 106
2023
Q3
$33.2M Sell
1,000,211
-42,423
-4% -$1.5M 0.33% 85
2023
Q2
$38.2M Sell
1,042,634
-7,188
-0.7% -$280K 0.35% 77
2023
Q1
$42.8M Sell
1,049,822
-20,019
-2% -$865K 0.43% 65
2022
Q4
$54.8M Sell
1,069,841
-36,711
-3% -$1.76M 0.57% 51
2022
Q3
$48.4M Buy
1,106,552
+4,246
+0.4% +$206K 0.55% 49
2022
Q2
$57.8M Buy
1,102,306
+52,790
+5% +$2.69M 0.62% 45
2022
Q1
$54.3M Buy
1,049,516
+243
+0% +$12.6K 0.5% 57
2021
Q4
$62M Buy
1,049,273
+14,406
+1% +$714K 0.56% 49
2021
Q3
$44.5M Sell
1,034,867
-40,555
-4% -$1.8M 0.44% 72
2021
Q2
$42.1M Buy
1,075,422
+166,149
+18% +$6.46M 0.42% 73
2021
Q1
$32.9M Sell
909,273
-47,655
-5% -$1.69M 0.4% 79
2020
Q4
$35.2M Sell
956,928
-75,861
-7% -$2.78M 0.46% 72
2020
Q3
$36M Sell
1,032,789
-37,798
-4% -$1.33M 0.53% 63
2020
Q2
$33.2M Sell
1,070,587
-73,483
-6% -$2.5M 0.52% 62
2020
Q1
$35.4M Sell
1,144,070
-84,575
-7% -$2.88M 0.66% 45
2019
Q4
$45.7M Sell
1,228,645
-68,096
-5% -$2.43M 0.69% 47
2019
Q3
$44.2M Sell
1,296,741
-101,230
-7% -$3.68M 0.71% 45
2019
Q2
$57.5M Sell
1,397,971
-50,178
-3% -$1.99M 0.93% 22
2019
Q1
$58.4M Sell
1,448,149
-87,608
-6% -$3.51M 0.96% 21
2018
Q4
$63.6M Sell
1,535,757
-21,591
-1% -$896K 1.14% 14
2018
Q3
$65.1M Sell
1,557,348
-79,323
-5% -$3.05M 1.02% 18
2018
Q2
$56.3M Sell
1,636,671
-138,340
-8% -$4.73M 0.94% 23
2018
Q1
$59.8M Sell
1,775,011
-263,991
-13% -$9.08M 0.99% 19
2017
Q4
$70.1M Buy
2,039,002
+27,923
+1% +$952K 1.12% 11
2017
Q3
$68.1M Buy
2,011,079
+41,180
+2% +$1.32M 1.15% 11
2017
Q2
$62.8M Buy
1,969,899
+32,148
+2% +$1.01M 1.1% 12
2017
Q1
$62.9M Buy
1,937,751
+112,869
+6% +$3.56M 1.12% 11
2016
Q4
$56.2M Sell
1,824,882
-32,985
-2% -$1.01M 1.02% 17
2016
Q3
$59.7M Buy
1,857,867
+547,596
+42% +$18.3M 1.11% 15
2016
Q2
$43.8M Sell
1,310,271
-164,997
-11% -$5.27M 1.09% 16
2016
Q1
$48.7M Buy
1,475,268
+120,028
+9% +$3.43M 1.19% 9
2015
Q4
$41.5M Sell
1,355,240
-77,602
-5% -$2.44M 1.05% 16
2015
Q3
$42.7M Sell
1,432,842
-74,030
-5% -$2.37M 1.12% 13
2015
Q2
$47.9M Buy
1,506,872
+35,912
+2% +$1.17M 1.16% 11
2015
Q1
$48.6M Sell
1,470,960
-63,867
-4% -$2.03M 1.19% 9
2014
Q4
$45.4M Sell
1,534,827
-201,467
-12% -$5.78M 1.08% 15
2014
Q3
$48.7M Sell
1,736,294
-100,090
-5% -$2.81M 1% 12
2014
Q2
$51.7M Sell
1,836,384
-109,786
-6% -$3.13M 1.02% 11
2014
Q1
$59.3M Buy
1,946,170
+274,069
+16% +$8.17M 1.14% 6
2013
Q4
$48.6M Sell
1,672,101
-7,780
-0.5% -$226K 1.28% 9
2013
Q3
$45.8M Buy
1,679,881
+7,474
+0.4% +$203K 1.36% 9
2013
Q2
$44.4M Buy
+1,672,407
New +$46.2M 1.38% 9

Other funds holding PFE

Huntington National Bank's PFE Position: Q2 2026 in Review

Huntington National Bank reduced its Pfizer (PFE) stake by 2.5% in Q2 2026, selling an estimated $460K and leaving 691,757 shares worth $16.7M. The position accounts for 0.08% of the portfolio, ranked #173.

Huntington National Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.1M in Q4 2017. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Huntington National Bank held 691,757 shares of Pfizer worth $16.7M as of Q2 2026.
  • Huntington National Bank sold 17,586 Pfizer shares in Q2 2026, an estimated $460K.
  • Pfizer made up 0.08% of Huntington National Bank's portfolio in Q2 2026, its #173 holding.
  • Huntington National Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Huntington National Bank's Pfizer position peaked at $70.1M in Q4 2017.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.